US › Healthcare

Journey Medical Corp (DERM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.36+0.96%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$18.5M

Revenue YoY

+23.3%

Net profit

$-312,000

EPS

$-0.01

EPS estimate

$-0.01

Net margin

-1.7%

EPS came in at -0.01 against a street estimate of -0.01 — a beat of 0.0%.

Key statistics

Market cap

$204.1M

Forward P/E

10.2

P/B

6.37

Book value

$1.16

EPS (TTM)

$-0.22

52-week high

$9.55

52-week low

$4.31

50-day MA

$6.99

200-day MA

$6.94

Beta

1.10

Analyst view

Analysts rate Journey Medical Corp a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $13.75.

Shareholding

Insiders

31.75%

Institutions

48.64%

Largest institutional holders

Fund	Stake
Wasatch Advisors LP	10.13%
TANG CAPITAL MANAGEMENT LLC	5.70%
Vanguard Capital Management, LLC	3.83%
BlackRock Inc	3.45%
Punch & Associates Inv Mgmt Inc	1.90%
Pale Fire Capital SE	1.87%
J. Goldman & Co LP	1.77%
Geode Capital Management, LLC	1.64%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Journey Medical Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.